Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05933083 · ClinicalTrials.gov registry record · NA

MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation

A NA study of Coronary Artery Disease and Myocardial Infarction, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
516
Enrollment target
5
Study locations

NCT05933083: Recruiting NA study of Coronary Artery Disease and Myocardial Infarction, sponsored by University of California, San Francisco.

NCT05933083 is a NA study of Coronary Artery Disease and Myocardial Infarction that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 516 participants, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (60% lower). The trial reports 5 study locations across 5 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05933083, a NA study of Coronary Artery Disease and Myocardial Infarction, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
516 participants
Enrollment target
5
Study locations

Study Summary

Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions. This study aims to compare two methods of delivering cardiac rehabilitation: in-person and through telehealth. The investigators want to know if the effects of these two programs are alike and if certain individuals benefit more from one program over the other.

Primary Outcome

The distance walked in six minute on a standard course will be measured in meters at baseline and 12 months.

Interventions

  • BEHAVIORAL In-person cardiac rehabilitation
  • BEHAVIORAL Telehealth cardiac rehabilitation

Study Locations (5)

California

  • University of California, San Francisco - San Francisco

Colorado

  • Denver Health - Denver

Maryland

  • Johns Hopkins University Medical Center - Baltimore

Michigan

  • University of Michigan - Ann Arbor

Pennsylvania

  • University of Pittsburgh Medical Center - Pittsburgh

Trial Details

FieldValue
Enrollment Target 516 participants
Start Date 2023-10-27
Est. Completion 2027-10-15
Phase NA

What NCT05933083 shows while recruiting

NCT05933083 is an interventional study that assigns participants to a tested intervention. The registered 516 participants enrollment target is mid-sized for trials with a published cap, below the 1,285-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (60% lower).

The record links to 6 conditions, with Coronary Artery Disease appearing as the primary indexed condition, and to 2 interventions - of which In-person cardiac rehabilitation is the first listed.

NCT05933083 lists 5 locations in 5 states (California, Colorado, Maryland).

Frequently Asked Questions

What is clinical trial NCT05933083 about?

NCT05933083 is a clinical study titled "MCNAIR Study: coMparative effeCtiveness of iN-person and teleheAlth cardIac Rehabilitation". Cardiac rehabilitation is a medically recommended program for patients with certain heart conditions. It includes exercise training, health education, and counseling. Unfortunately, many patients do not participate in cardiac rehabilitation. Some find it challenging to attend the in-person sessions....

What is the current status of trial NCT05933083?

This trial is currently recruiting. It is a NA study. The enrollment target is 516 participants. The study started on 2023-10-27. Estimated completion is 2027-10-15.

What conditions does trial NCT05933083 study?

This clinical trial studies the following conditions: Coronary Artery Disease, Myocardial Infarction, Heart Failure, Systolic, Heart Valve Diseases, Heart Transplant.

What interventions are being tested in trial NCT05933083?

The interventions under investigation include: In-person cardiac rehabilitation (BEHAVIORAL), Telehealth cardiac rehabilitation (BEHAVIORAL).

Who is sponsoring clinical trial NCT05933083?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05933083 being conducted?

This trial has 5 study locations across California, Colorado, Maryland, Michigan, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT05933083's enrollment target sits among peer trials

516 73rd of 219 higher than 147 of 219 other Coronary Artery Disease trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Coronary Artery Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05676450 · 517 participants · NA

    Feasibility and Clinical Utility of Cell-free DNA (cfDNA) in Identifying Actionable Alterations and Minimal Residual Disease for Lymphoma Patients Across Community Centers in Texas

  • NCT05577819 · 515 participants · NA

    Prevalence and Prediction of ATTR in Ambulatory Patients With HFpEF

  • NCT06804837 · 515 participants · NA

    Implement and Test Visual Consent Template and Process

  • NCT04524871 · 518 participants · Phase 1

    A Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients With Advanced Liver Cancers (Morpheus-Liver)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05933083, the US trial registry maintained by the National Library of Medicine. NCT05933083 (mid enrollment · multi site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.